Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Most patients ...
Which patients is this strategy targeting? The inclusion was limited to stage I patients, presentations no longer considered locally advanced. Matted nodes were excluded explicitly, and the high ...
PHILADELPHIA – A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results